FDA-approved drug shows promise against ALS in mice

Accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of amyotrophic lateral sclerosis (ALS).

Harvard Gazette | Nov. 27, 2019 | harvard
~3 mins   

Tags: health-medicine als amyotrophic-lateral-sclerosis basic-research cromolyn-sodium inflammation

Page 1 of 1